… colorectal cancer preventive therapy in age-stratified groups, as highlighted by the recently
updated US Preventive Services Task Force guidelines which recommend aspirin for primary …

Colorectal cancer (CRC) accounts for about 10% of cancer mortality in the United States,
causing 57,000 deaths in 2004 alone [1]. Approximately 146,000 new cases of CRC are …

… rectal examination reduces mortality from colorectal cancer, and it is not indicated as a
screening test for the prevention or early detection of colorectal cancer, although it is commonly …

… Colorectal cancer (CRC) is the second most common fatal malignancy in the … preventive
therapies. Both genetic and epigenetic factors contribute to the development of colorectal cancer…

In this review, we discuss the available experimental evidences supporting the chemopreventive
efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) on colorectal cancer and the …

Colorectal cancer (CRC) has been ranked as the third most prevalent cancer worldwide. …
therapies, the mortality rate of CRC has decreased by more than 20% in the last decade. …

Background: Triglycerides (TG) are one of the major constituents of body fat and energy
reservoir, which consist of an ester derived from glycerol and three free fatty acids. TG lipase, …

… Worldwide, colorectal cancer (CRC) remains a major cancer type and leading cause of death.
Unfortunately, current medical treatments are not sufficient due to lack of effective therapy, …

… Although the incidence of colorectal cancer (CRC) has been declining in recent decades, it
… a leading cause of cancer mortality and morbidity worldwide. Prevention is one milestone for …

… basis of these effects in preventing the risk and recurrence of colorectal cancer (CRC) and
decreasing the hazards of cancer and cancer treatment. Several observational studies have …